Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.

Dörr T, Vulić M, Lewis K. · 2010

Read Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. by Dörr T, Vulić M, Lewis K. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2826370.txt.

Introduction

Dörr, Vulić, and Lewis found in 2010 how a common antibiotic tricks some E. coli bacteria into a dormant state that shrugs off drugs. These sleeper cells, called persisters, survive treatment without being genetic mutants and help stubborn biofilm infections return. How they form had resisted years of screening.

The antibiotic ciprofloxacin damages bacterial DNA, which switches on the cell's SOS alarm. That alarm raises production of TisB, a tiny protein that pokes into the cell membrane and drains its energy. Drained cells go dormant and tolerate many antibiotics at once. Deleting the tisB gene cut persister formation sharply, giving the first single-gene handle on a mechanism long thought to be fully redundant.

Catalog record

CREATORDörr T, Vulić M, Lewis K.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2826370

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli By Tobias Dörr, Marin Vulić, Kim Lewis, Matt K Waldor Published in: PLoS Biology DOI: 10.1371/journal.pbio.1000317 ABSTRACT Persisters are specialized survivor cells that arise in populations of E. coli after antibiotic-mediated DNA damage induces the production of a small membrane-acting peptide TisB, which causes reversible dormancy. The TisB-dependent persisters are tolerant to multiple antibiotics. INTRODUCTION Bacterial populations form persisters, dormant cells that are highly tolerant to antibiotics and play an important role in recalcitrance of biofilm infections [1],[2]. Time-dependent or dose-dependent killing by antibiotics is distinctly biphasic, revealing a surviving subpopulation of persister cells. Reinoculation of surviving cells produces a culture with a new subpopulation of persisters, showing that these cells are not mutants, but rather phenotypic variants of the wild type [3],[4]. Re-exposure of persisters to a different bactericidal antibiotic resulted in little or no additional killing, showing that persisters are multidrug-tolerant cells [5]. Gain-of-function mutants in the E. coli hipA toxin gene lead to an increase in the frequency of ampicillin- and fluoroquinolone-tolerant persisters in a growing population from 1 in 10,000 cells or less (wild-type levels) to 1 in 100 cells [6]–[10], and this hipA7 mutant was shown to form persisters prior to addition of antibiotic [11]. These persisters were slow- or nongrowing cells. Wild-type persisters have been isolated from an exponential culture of E. coli untreated with antibiotic, by sorting out dim cells of a strain expressing a degradable GFP that is transcriptionally fused to a ribosomal RNA promoter [12]. This indicated that persisters are cells that have diminished protein synthesis and are dormant. The apparent dormancy of persisters accounts for their tolerance to bactericidal antibiotics whose action requires an active, functional target [13]–[16]. The mechanism of persister formation is currently unknown. Isolated persisters show increased expression levels of chromosomal toxin/antitoxin (TA) genes [9],[12]. Ectopic overproduction of RelE, an mRNA endonuclease [17], inhibits protein synthesis and creates dormant, multidrug-tolerant cells [9]. The HipA protein is an Ef-Tu kinase [18],[19], which also inhibits protein synthesis and produces multidrug-tolerant cells upon overproduction. However, strains deleted in individual TA loci do not have a phenotype [9],[12], possibly due to their functional redundancy [20]–[22]. In E. coli, there are at least 15 TA modules [20],[22],[23]. Importantly, a screen of an ordered 3,985 open reading frame (out of a total of 4,288) knockout library of E. coli [24] for mutants lacking persisters in stationary phase produced a largely negative result—not a single strain lacking persister formation was identified [25]. Similar negative findings were reported with screens of E. coli transposon insertion (Tn) libraries [26],[27] and a Pseudomonas aeruginosa Tn library [28]. Only mutants with modest reduction in persister levels were identified, and in the case of E. coli, these were primarily in global regulators [25]. This strongly suggests that there are multiple, redundant mechanisms of persister formation. Persisters were originally described by Bigger in 1944 [3], but functional redundancy has made it very challenging to elucidate the mechanism by which they form. A useful clue to a possible mechanism of persister formation comes from the analysis of the SOS response. Interestingly, SOS induces several TA genes in E. coli, whose promoters contain a Lex box: symER, hokE, yafN/yafO, and tisAB/istR [23],[29]–[35] Another locus, dinJ/yafQ, contains a Lex box but is not believed to be under SOS control [29],[30]. Importantly, only the toxin gene is predicted to be up-regulated in the three type 1 TA modules (symER, hokE, and tisAB/istR) following SOS induction, whereas in the type 2 TA modules, toxin and antitoxin form an operon and are therefore both expected to be induced. Fluoroquinolones such as ciprofloxacin induce the SOS response [36] by blocking the ligase activity of DNA gyrase and topoisomerase, converting them into endonucleases [14],[37]. In a separate study, we have shown that the SOS response is also necessary for persister formation in response to the fluoroquinolone antibiotic ciprofloxacin [38]. In the present study, we examine the mechanism of this ciprofloxacin-induced persister formation and find that it is governed by the TisB toxin. RESULTS Ciprofloxacin rapidly killed the bulk of E. coli cells, leaving surviving persisters (Figure 1). Strains deleted in one of the five SOS-TA loci were examined for time-dependent killing by ciprofloxacin, and one of them, ΔtisAB (GenBank accession number NC_000913), had a sharply decreased level of persisters (Figure 1A). This suggests that the majority of persisters, ≥90%, were formed in response to ciprofloxacin treatment, and their production is dependent on tisAB. Introduction of tisAB in single copy into the lambda attachment site of the ΔtisAB strain complemented the low persister phenotype of the knockout strain (Figure 1B). Persister levels observed in time-dependent killing experiments with ampicillin or streptomycin that do not cause DNA damage were unchanged in the ΔtisAB strain (unpublished data). Ampicillin has been reported to induce the SOS response [39], but apparently the level of induction is insufficient to influence TisB-dependent persister formation. [Figure: Survival of the tisAB/istR mutants after ciprofloxacin exposure and complementation of the phenotype.(A) Knockout strains of the toxin locus tisAB and its antitoxin istR-1 were exposed to 1 μg/ml ciprofloxacin in exponential growth phase and survival determined by spot plating for colony forming units. The graph is a representative of at least five independent experiments with similar results, error bars indicate the standard error. (B) MG1655 ΔtisAB carrying the tisAB region as a single-copy insertion in the lambda attachment site was treated as described in (A). wt, wild type.] IstR-1 is an antisense RNA antitoxin that is expressed constitutively from its own, LexA-independent promoter and controls the production of the TisB toxin [28]. IstR-2 is a longer small RNA transcript that is LexA controlled and contains the entire IstR-1 RNA sequence. IstR-2, however, has been suggested not to be involved in the control of TisB production [40]. tisA is an untranslated open reading frame that contains the antisense RNA binding site as well as the ribosome binding site for tisB [32]. A schematic of the tisAB/istR locus based on [40] is shown in Figure 2. [Figure: Schematic of the tisAB/istR locus.Only the LexA-controlled toxin tisB is translated in vivo; tisA contains the binding site for the constitutively expressed antitoxin RNA IstR-1 [36]. The IstR-2 RNA is under LexA control and contains the entire IstR-1 RNA. Its role in tisAB regulation is currently unclear.] A strain deleted in istR-1 caused a marked, 10- to 100-fold increase in the level of persisters (Figure 1A). This is consistent with increased levels of TisB leading to persister formation. This result is also in apparent contradiction to a published study showing that ectopic expression of tisB kills cells [41]. It seems likely that the high levels of expression from the multicopy plasmid used in the above-cited study were responsible for cell death. Importantly, the minimal inhibitory concentration (MIC) of ciprofloxacin for tisAB and istR-1 knockouts was the same as in the wild type, showing that these genes do not affect resistance to this antibiotic, but rather control drug tolerance by modulating persister production. To test whether IstR-2 was also involved in tisB regulation in persisters, we produced a knockout of the istR-2 promoter region and tested it for ciprofloxacin-induced persister formation. Unexpectedly, the

Read the complete text